These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6678555

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A, Sacerdoti D, Merkel C, Rossoni R, Finucci G, Bolognesi M, Zuin R.
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [Abstract] [Full Text] [Related]

  • 4. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Cavasin L, Gatta A.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):433-9. PubMed ID: 16128681
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV, Drozdov VN, Mikheeva OM, Petrakov AV.
    Eksp Klin Gastroenterol; 2008 Sep 01; (5):37-41. PubMed ID: 19145915
    [No Abstract] [Full Text] [Related]

  • 8. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP, Dubinskiĭ AA, Tereshkin IG.
    Vrach Delo; 1989 Nov 01; (11):19-22. PubMed ID: 2609578
    [Abstract] [Full Text] [Related]

  • 9. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW, Kalk JF, Klein CP.
    Hepatology; 1999 Feb 01; 29(2):334-9. PubMed ID: 9918907
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F, Chiarini C, Degli Esposti E, Santoro A, Sturani A, Zuccalà A, Zucchelli P.
    Clin Ter; 1983 Aug 15; 106(3):209-12. PubMed ID: 6627892
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.
    Gatta A, Sacerdoti D, Merkel C, Milani L, Battaglia G, Zuin R.
    Am Heart J; 1984 Oct 15; 108(4 Pt 2):1167-72. PubMed ID: 6148880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.